QA

Quazi Abdul Wali

Active Director Additional Director DIN 11093614
DIN 11093614 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Total affiliations 4 Since May 2025
Shareholding value •••• Premium profile

About Quazi Abdul Wali

Data last updated:

Quazi Abdul Wali is an Additional Director at Primecare Pharma Private Limited (since 2025), Director at Primecare Medical Services And Multispeciality Clinics (India) Private Limited (since 2025) and Additional Director at Citilab Healthcare (India) Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma, Healthcare and Real Estate. The 3 current companies with reported revenue have a combined latest revenue of ₹67.10 Cr; the largest is Primecare Pharma Private Limited at ₹33.78 Cr (FY 2024).

DIN 11093614
Primary Designation Additional Director
Industry Pharma
First Appointment 06 May 2025
Oldest Company Age 13 yrs
Largest company Primecare Pharma Private Limited · ₹33.78 Cr (FY 2024)
Combined revenue ₹67.10 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Primecare Pharma Private Limited U74999KA2018PTC111171
Additional Director06 May 20252018₹33.78 Cr (FY 2024)Active
Director06 May 20252012₹32.10 Cr (FY 2025)Active
Additional Director30 May 20252015₹1.22 Cr (FY 2025)Active
Coreshelters Infra Private Limited U42900KA2024PTC184068
Additional Director24 Jun 20252024Active

Directorship timeline

Open interactive timeline →
Primecare Pharma Private Limited
Primecare Medical Services And Multispeciality Clinics (India) Private Limited
Coreshelters Infra Private Limited
Citilab Healthcare (India) Private Limited
Premium access

Shareholding and investment profile for Quazi Abdul Wali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Quazi Abdul Wali

Quazi Abdul Wali currently holds 4 directorships: Primecare Pharma Private Limited (Additional Director, since 06 May 2025, revenue ₹33.78 Cr (FY 2024)); Primecare Medical Services And Multispeciality Clinics (India) Private Limited (Director, since 06 May 2025, revenue ₹32.10 Cr (FY 2025)); Citilab Healthcare (India) Private Limited (Additional Director, since 30 May 2025, revenue ₹1.22 Cr (FY 2025)); Coreshelters Infra Private Limited (Additional Director, since 24 Jun 2025).

Quazi Abdul Wali was first appointed on 06 May 2025 as Additional Director at Primecare Pharma Private Limited.

The 3 current companies of Quazi Abdul Wali that report revenue have a combined latest revenue of ₹67.10 Cr: Primecare Pharma Private Limited ₹33.78 Cr (FY 2024); Primecare Medical Services And Multispeciality Clinics (India) Private Limited ₹32.10 Cr (FY 2025); Citilab Healthcare (India) Private Limited ₹1.22 Cr (FY 2025).

The current boards of Quazi Abdul Wali's companies include Mohamed Umar Nayaz (Primecare Pharma Private Limited), Parveez Ahmed (Primecare Pharma Private Limited), Sayed Jawad Wajid (Primecare Pharma Private Limited), Thummalakuntla Venkata Sivudu (Primecare Pharma Private Limited), Venkatapathi Naidu Bharani (Primecare Pharma Private Limited), Lucky Mittal (Primecare Medical Services And Multispeciality Clinics (India) Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available